Ovid Therapeutics to Present at the Jefferies Biotech CNS/Ne

NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with epilepsies and seizure-related

Related Keywords

New York , United States , Maeve Conneighton , Exchange Commission , Ovid Therapeutics Inc , Nasdaq , Jefferies Inaugural Biotech , Neuro Summit , New York Based , Quarterly Report , Region ,